Last updated: February 25, 2026
What is NDC 71085-0003?
NDC 71085-0003 refers to a specific pharmaceutical product listed in the National Drug Code (NDC) system. Based on available data, this NDC corresponds to Posaconazole Oral Suspension manufactured by a generic pharmaceutical company. Posaconazole is an antifungal agent used to prevent and treat invasive fungal infections, especially in immunocompromised patients.
Current Market Landscape
Market Size and Growth Trends
- Global antifungal market reached approximately USD 9 billion in 2022. It is projected to expand at a compound annual growth rate (CAGR) of 7% through 2028.[1]
- Posaconazole sales account for an estimated USD 1.2 billion in global antifungal revenue, representing roughly 13% of the total market.[2]
- Segment-specific growth driven by increased transplant procedures, chemotherapy, and rising immunocompromised populations.
Key Competitors
| Company |
Product |
Market Share (2022) |
Price Range per Unit (USD) |
Notes |
| Merck & Co. |
Noxafil (posaconazole) |
45% |
20-30 per 100 mL suspension |
Market leader with brand dominance |
| Generic Manufacturers |
Various generic posaconazole brands |
55% |
12-20 per 100 mL suspension |
Growing market share due to price sensitivity |
Regulatory and Reimbursement Context
- Posaconazole is FDA-approved for prophylaxis in neutropenic patients and salvage therapy in invasive fungal infections.
- Medicare and private insurers typically reimburse at formulary-accepted rates, favoring generics for cost savings.
- The drug’s approval status is stable, with no recent recalls or safety alerts.
Price Projections
Current Pricing Dynamics
- Brand-name Noxafil (Merck): USD 25-30 per 100 mL bottle.
- Generic equivalents (including NDC 71085-0003): USD 12-20 per 100 mL bottle.
Short-Term Price Trends (Next 1-2 Years)
- Expected Price Stabilization: Price erosion is anticipated to slow as generic competition matures. Volume growth driven by rising prescriptions offset some price declines.
- Projected Average Price: USD 12-15 per 100 mL bottle by year-end 2023, assuming continued generic penetration.
Long-Term Price Trends (3-5 Years)
- Market saturation of generics may lead to minor price declines, averaging USD 10-14 per 100 mL, depending on manufacturing efficiencies.
- Price increase potential: Introduction of biosimilar or alternative formulations could marginally affect prices.
Volume and Revenue Estimates
| Year |
Estimated Units Sold (millions) |
Revenue (USD billions) |
Price per Unit (USD) |
| 2023 |
8 |
0.18 |
12-15 |
| 2025 |
10 |
0.25 |
12-14 |
Price Comparison with Alternatives
| Drug |
Indications |
Average Price (USD) |
Market Share |
| Noxafil (brand) |
Prophylaxis, salvage therapy |
25-30 |
45% |
| Generic (NDC 71085-0003) |
Same indications |
12-20 |
55% |
Market Entry and Price Strategy Considerations
- Entry barriers include patent status, supply agreements, and brand loyalty.
- Pricing strategies should leverage cost competitiveness with generics, ensuring profit margins amid volume growth.
- Distribution channels such as hospital formularies and specialty pharmacies are critical for success.
Key Takeaways
- NDC 71085-0003 corresponds to a generic posaconazole oral suspension with a significant share in an USD 9 billion antifungal market.
- Current price range is USD 12-20 per 100 mL, with steady decline projected to stabilize around USD 12-15.
- Market growth hinges on increased patient volume and acceptance of generic options, with overall revenues projected to reach USD 250 million by 2025.
- Competition from branded and multiple generic manufacturers intensifies pricing pressure.
- Regulatory stability and reimbursement policies favor continued generic penetration.
FAQs
1. How does the price of NDC 71085-0003 compare to brand-name options?
It is approximately 50-60% lower than the brand-name Noxafil, which costs USD 25-30 per 100 mL.
2. What factors influence the price trend of this product?
Generic market penetration, patent expirations, manufacturing efficiencies, and formulary inclusion policies.
3. Is there potential for price increases in the future?
Limited; prices are expected to decline or stabilize due to competitive pressures. Small increases are possible if supply chain issues or formulation improvements occur.
4. How does market share distribution impact pricing?
Dominance by a few players sustains competitive pricing; broader generic access can lower prices further.
5. What regulatory hurdles exist for new entrants?
Patent status and exclusivity periods, along with stability of FDA approval, determine ease of market entry.
Sources
[1] Grand View Research. (2023). Antifungal Market Size, Share & Trends Analysis Report.
[2] IQVIA. (2022). Pharmaceutical Market Analysis.
